earnings
confidence high
sentiment negative
materiality 0.75
INBS Q2 FY2025 revenue falls 20% YoY; net loss widens to $2.26M; gross margin up 11pts
INTELLIGENT BIO SOLUTIONS INC.
2025-Q2 EPS reported
-$1.18
revenue$1,739,549
- Revenue $607,494, down 20% YoY; net loss $2.25M vs $1.97M.
- Gross margin for six months improved to 38.5% from 27.7% on higher cartridge sales.
- FDA 510(k) submitted in Dec 2024; planning US market entry in 2025.
- Cash $2.24M; equity $4.20M as of Dec 31, 2024.
- Added 19 accounts; total 400+ active accounts in 19 countries.